Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.

Spentzos D, Cannistra SA, Grall F, Levine DA, Pillay K, Libermann TA, Mantzoros CS.

Endocr Relat Cancer. 2007 Sep;14(3):781-90.

2.

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

Spentzos D, Levine DA, Kolia S, Otu H, Boyd J, Libermann TA, Cannistra SA.

J Clin Oncol. 2005 Nov 1;23(31):7911-8. Epub 2005 Oct 3.

PMID:
16204010
3.

Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review.

Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, Noguchi T, Sakata M, Yamada Y, Oi H, Kobayashi H.

Int J Gynecol Cancer. 2009 Aug;19(6):992-7. doi: 10.1111/IGC.0b013e3181aaa93a. Review.

PMID:
19820358
4.

Gene expression profiles as prognostic markers in women with ovarian cancer.

Jochumsen KM, Tan Q, Høgdall EV, Høgdall C, Kjaer SK, Blaakaer J, Kruse TA, Mogensen O.

Int J Gynecol Cancer. 2009 Oct;19(7):1205-13. doi: 10.1111/IGC.0b013e3181a3cf55.

PMID:
19823056
5.

Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA, Cannistra SA.

J Clin Oncol. 2004 Dec 1;22(23):4700-10. Epub 2004 Oct 25. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15505275
6.
7.

[Expression and prognostic significance in epithelial ovarian cancer].

Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M.

Minerva Ginecol. 2002 Feb;54(1):15-24. Italian.

PMID:
11828267
8.

Gene expression and prognostic significance in ovarian cancer.

Tammela J, Odunsi K.

Minerva Ginecol. 2004 Dec;56(6):495-502. Review.

PMID:
15729202
9.

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer.

Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D, Mutirangura A.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):711-7. Epub 2007 Oct 18.

PMID:
17944913
10.

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.

Vermeij R, de Bock GH, Leffers N, Ten Hoor KA, Schulze U, Hollema H, van der Burg SH, van der Zee AG, Daemen T, Nijman HW.

J Immunother. 2011 Jul-Aug;34(6):516-23. doi: 10.1097/CJI.0b013e31821e012f.

PMID:
21654520
11.
12.

Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer.

Howells RE, Dhar KK, Hoban PR, Jones PW, Fryer AA, Redman CW, Strange RC.

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):242-50.

PMID:
15086723
13.

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I; Australian Ovarian Cancer Study Group., Gertig D, DeFazio A, Bowtell DD.

Clin Cancer Res. 2008 Aug 15;14(16):5198-208. doi: 10.1158/1078-0432.CCR-08-0196.

14.

Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancer.

Ozalp SS, Yalcin OT, Basaran GN, Artan S, Kabukcuoglu S, Minsin TH.

Eur J Gynaecol Oncol. 2000;21(3):282-6.

PMID:
10949395
15.

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.

Bachvarov D, L'esperance S, Popa I, Bachvarova M, Plante M, Têtu B.

Int J Oncol. 2006 Oct;29(4):919-33.

PMID:
16964388
16.

EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy.

Kataoka F, Tsuda H, Arao T, Nishimura S, Tanaka H, Nomura H, Chiyoda T, Hirasawa A, Akahane T, Nishio H, Nishio K, Aoki D.

Genes Chromosomes Cancer. 2012 Mar;51(3):300-12. doi: 10.1002/gcc.21916. Epub 2011 Nov 17.

PMID:
22095904
17.

Gene expression patterns that characterize advanced stage serous ovarian cancers.

Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A.

J Soc Gynecol Investig. 2004 Jan;11(1):51-9.

PMID:
14706684
18.

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.

Warrenfeltz S, Pavlik S, Datta S, Kraemer ET, Benigno B, McDonald JF.

Mol Cancer. 2004 Oct 7;3:27.

19.
20.

Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.

Shimogai R, Kigawa J, Itamochi H, Iba T, Kanamori Y, Oishi T, Shimada M, Sato S, Kawaguchi W, Sato S, Terakawa N.

Int J Gynecol Cancer. 2008 May-Jun;18(3):499-505. doi: 10.1111/j.1525-1438.2007.01055.x.

PMID:
18476949

Supplemental Content

Support Center